Crewe Advisors’s GSK GSK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $12.5K | Buy |
325
+61
| +23% | +$2.34K | ﹤0.01% | 430 |
|
2025
Q1 | $10.2K | Hold |
264
| – | – | ﹤0.01% | 424 |
|
2024
Q4 | $8.93K | Hold |
264
| – | – | ﹤0.01% | 438 |
|
2024
Q3 | $10.8K | Hold |
264
| – | – | ﹤0.01% | 483 |
|
2024
Q2 | $10.2K | Hold |
264
| – | – | ﹤0.01% | 688 |
|
2024
Q1 | $11.3K | Buy |
+264
| New | +$11.3K | ﹤0.01% | 601 |
|
2023
Q4 | – | Sell |
-264
| Closed | -$9.57K | – | 537 |
|
2023
Q3 | $9.57K | Hold |
264
| – | – | ﹤0.01% | 247 |
|
2023
Q2 | $9.41K | Hold |
264
| – | – | ﹤0.01% | 415 |
|
2023
Q1 | $9.39K | Hold |
264
| – | – | ﹤0.01% | 559 |
|
2022
Q4 | $9.28K | Hold |
264
| – | – | ﹤0.01% | 563 |
|
2022
Q3 | $8K | Hold |
264
| – | – | ﹤0.01% | 726 |
|
2022
Q2 | $14K | Hold |
264
| – | – | ﹤0.01% | 516 |
|
2022
Q1 | $14K | Hold |
264
| – | – | ﹤0.01% | 332 |
|
2021
Q4 | $15K | Hold |
264
| – | – | ﹤0.01% | 288 |
|
2021
Q3 | $13K | Hold |
264
| – | – | ﹤0.01% | 243 |
|
2021
Q2 | $13K | Hold |
264
| – | – | ﹤0.01% | 256 |
|
2021
Q1 | $12K | Hold |
264
| – | – | ﹤0.01% | 264 |
|
2020
Q4 | $12K | Sell |
264
-30
| -10% | -$1.36K | ﹤0.01% | 239 |
|
2020
Q3 | $14K | Buy |
294
+30
| +11% | +$1.43K | 0.01% | 212 |
|
2020
Q2 | $13K | Hold |
264
| – | – | 0.01% | 154 |
|
2020
Q1 | $13K | Sell |
264
-54
| -17% | -$2.66K | 0.01% | 135 |
|
2019
Q4 | $19K | Buy |
318
+54
| +20% | +$3.23K | 0.01% | 154 |
|
2019
Q3 | $14K | Hold |
264
| – | – | 0.01% | 172 |
|
2019
Q2 | $13K | Hold |
264
| – | – | ﹤0.01% | 202 |
|
2019
Q1 | $14K | Hold |
264
| – | – | ﹤0.01% | 171 |
|
2018
Q4 | $13K | Hold |
264
| – | – | ﹤0.01% | 175 |
|
2018
Q3 | $13K | Hold |
264
| – | – | 0.01% | 188 |
|
2018
Q2 | $13K | Hold |
264
| – | – | 0.01% | 197 |
|
2018
Q1 | $13K | Sell |
264
-199
| -43% | -$9.8K | 0.01% | 209 |
|
2017
Q4 | $21K | Buy |
+463
| New | +$21K | 0.02% | 190 |
|